Premium
P4‐001: CHANGES IN FRONTOCORTICAL INTERSTITIAL FLUID LEVELS OF BETA‐AMYLOID AND TAU PROTEIN IN TRANSGENIC MICE MODELS OF ALZHEIMER'S DISEASE
Author(s) -
Gobert Alain,
RollinJego Gaelle,
Iop Fabrice,
Rivet Jean Michel,
Favale Dominique,
Danober Laurence,
Dix Sophie,
Czech Christian,
Laurence Ozmen,
Richardson Jill,
Schenker Esther
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - French
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.1515
Subject(s) - microdialysis , interstitial fluid , chemistry , monoamine neurotransmitter , amyloid (mycology) , entorhinal cortex , genetically modified mouse , tau protein , medicine , pathology , hippocampal formation , endocrinology , alzheimer's disease , transgene , biochemistry , extracellular , serotonin , disease , receptor , gene
WEDNESDAY, JULY 16, 2014 POSTER PRESENTATIONS P4 P4-001 CHANGES IN FRONTOCORTICAL INTERSTITIAL FLUID LEVELS OF BETA-AMYLOID AND TAU PROTEIN IN TRANSGENIC MICE MODELS OF ALZHEIMER’S DISEASE Alain Gobert, Gaelle Rollin-Jego, Fabrice Iop, Jean Michel Rivet, Dominique Favale, Laurence Danober, Sophie Dix, Christian Czech, Ozmen Laurence, Jill Richardson, Esther Schenker, Institut de Recherches Servier, Croissy sur Seine, France; Institut de Recherches Servier, Croissy sur Seine, France; Institut de Recherches Servier, Croissy sur Seine, France; Eli Lilly, Lilly Research Centre, Surrey, United Kingdom; CNS Research, Hoffmann-La Roche AG, Basel, Switzerland; F. Hoffmann-LaRoche AG, Basel, Switzerland; GlaxoSmithKline Research and Development, China Group, Stevenage, United Kingdom; Institut de Recherches Servier, Croissy sur Seine, France. Contact e-mail: alain.gobert@fr.netgrs.com